Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Enterome Announces First Patient Dosed in a Phase 1/2 Trial with Second OncoMimics™ Vaccine, EO2463, in Non-Hodgkin Lymphoma
Enterome SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to […]
HIV Vaccine Trial HIV-CORE 0052 Starts at Oxford
The goal of the trial, known as HIV-CORE 0052, is to evaluate the safety, tolerability, […]
Sequanta and Mission Bio Announce Strategic Partnership
Sequanta Technologies Co., Ltd. and Mission Bio are pleased to announce that they have entered […]
IntraOp Announces First Patients Enrolled in FLASH Clinical Trial
IntraOp Medical Corporation announced today that Lausanne University Hospital (CHUV, Switzerland) enrolled the first patients in the Impulse […]
Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today […]
NHS Mental Health Crisis Helplines Receive Three Million Calls
Mental health helplines run by the NHS have answered around three million calls during the […]
UnitedHealthcare Introduces the Use of Predictive Analytics to Expand its Capabilities to Address Social Determinants of Health
UnitedHealthcare has introduced the use of predictive analytics to help improve well-being, lower costs and […]
Arab Participation in Global Genomic Study Could Lead to New Therapies for COVID-19 Patients
In March 2020, thousands of scientists around the world united to answer a pressing and […]
Waits For Treatment Drop As NHS Bounces Back
The number of people waiting longer than 18 and 52 weeks to begin non-urgent treatment […]
PHE to Provide Genomic Sequencing Support to Partners Across the World
PHE Platform NVAP was announced in January by the Department of Health and Social Care […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more